Pharmaceuticals, namely, preparations for antibody and antibody-derivative development Biological preparations for use in industry and science, namely, preparations for antibody development

Classification Information

Class [001]
Chemical Products

Biological preparations for use in industry and science, namely, preparations for antibody development

First Use Date in General

07^th Aug 2017

First Use Date in Commerce

07^th Aug 2017

Class [005]
Pharmaceutical Products

Pharmaceuticals, namely, preparations for antibody and antibody-derivative development

First Use Date in General

07^th Aug 2017

First Use Date in Commerce

07^th Aug 2017

Mark Details

Serial Number

No 88238389

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 000118T002US

44D Filed

44D Current

44E filed

44E Current

66A Filed

66A Current

Current Basis

No Basis

Legal History

Status Date	Action Taken
08^th Nov 2021	ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
08^th Nov 2021	ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
20^th Apr 2021	NOTIFICATION OF FINAL REFUSAL EMAILED
20^th Apr 2021	SU - FINAL REFUSAL - WRITTEN
20^th Apr 2021	FINAL REFUSAL E-MAILED
30^th Mar 2021	TEAS/EMAIL CORRESPONDENCE ENTERED
30^th Mar 2021	CORRESPONDENCE RECEIVED IN LAW OFFICE
26^th Mar 2021	TEAS RESPONSE TO OFFICE ACTION RECEIVED
29^th Sep 2020	NOTIFICATION OF NON-FINAL ACTION E-MAILED
29^th Sep 2020	NON-FINAL ACTION E-MAILED

ALIVAMAB

Classification Information

Class [001]Chemical Products

First Use Date in General

First Use Date in Commerce

Class [005]Pharmaceutical Products

First Use Date in General

First Use Date in Commerce

Mark Details

Serial Number

Mark Type

Attorney Docket Number

44D Filed

44D Current

44E filed

44E Current

66A Filed

66A Current

Current Basis

No Basis

Legal History

Class [001]
Chemical Products

Class [005]
Pharmaceutical Products